Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine + Ofatumumab in Untreated Indolent NHL
NCT01108341Phase 2Completed
- Sponsor
- Cephalon, Inc.
- Start
- May 2010
- Primary completion
- Jul 2011
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of bendamustine, ofatumumab in B-cell non-Hodgkin lymphoma, sponsored by Cephalon, Inc.. Started May 2010; status: completed.
02
Drugs
bendamustineofatumumab
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT01108341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01108341.